Navigating the Complexities of ESG Bonds - MSCI
US88166JAA16 Institutional Ownership - Teva Pha Fin Bv 3.65% 11/21
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
USD Cash Spreads Widen But Bonds Rise With Lower Rates Across The Curve | ϕpost: News & Analyses of Capital Markets
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
A1ZZHS | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,250 % bis 31.03.2023 | finanzen.net
PharmaBoardroom - Teva Netherlands
Lening Teva Pharmaceutical 3,15% 2026 pas ex-coupon gegaan en beschikbaar onder pari | OBLIS
Teva Pharmaceutical Finance Netherlands II B.V. (Director) - Curaçao
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
A1VQDB | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,625 % bis 15.10.2028 | finanzen.net
BlackRock Inc. ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
ağır insansız cümle teva pharmaceutical finance netherlands ii bv - shreesuppliers.com
A1ZZHM | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,875 % bis 31.03.2027 | finanzen.net
ağır insansız cümle teva pharmaceutical finance netherlands ii bv - shreesuppliers.com
ağır insansız cümle teva pharmaceutical finance netherlands ii bv - shreesuppliers.com
ağır insansız cümle teva pharmaceutical finance netherlands ii bv - shreesuppliers.com
TEVJF Institutional Ownership - Teva Pharmaceutical Industries Ltd. (OTC) Stock
PharmaBoardroom - Teva Pharma Belgium
Capital Research Global Investors ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement - FactEntry
